Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Otten

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Pharmacy World & Science : PWS|November 24, 1995
Prospects of immunotherapy for rheumatoid arthritisB A t Hart, H G Otten
Frontiers in Immunology|September 8, 2022
Editorial: A hill of needs: Non-HLA antibodies and transplantationH G Otten, Mélanie Dieudé, Michelle J Hickey
Scandinavian Journal of Rheumatology. Supplement|January 1, 1995
Rheumatoid factor production in the jointF C Breedveld, H G Otten, M R Daha
Immunology Today|June 1, 1996
Primary T-cell responses induced by B7-transfected keratinocytesH G Otten, C Ververs, G C de Gast
Leukemia & Lymphoma|June 28, 2001
Prevention of acute graft-versus-host-disease by selective depletion of T cells reactive with minor histocompatibility antigens on epithelial cellsH G Otten, A M Van Dyk, L F Verdonck
Transplant Immunology|September 8, 2014
Humoral immunity and complement effector mechanisms after lung transplantationK Budding, E A van de Graaf, H G Otten
British Journal of Rheumatology|July 1, 1993
The relation between class-specific serum rheumatoid factors and age in the general populationD van Schaardenburg, A M Lagaay, H G Otten, et al.
Scandinavian Journal of Immunology|July 1, 1992
Reactivity and self-association in vivo of a human monoclonal IgG rheumatoid factorH G Otten, M R Daha, H H De Rooy, et al.
Clinical and Experimental Rheumatology|November 1, 1995
Clinical application of the polymerase chain reaction in the detection of HLA-B27 allelesH G Otten, M van Soest, J W Bijlsma, et al.
Leukemia|June 25, 2004
Prevalence and clinical significance of resistance to perforin- and FAS-mediated cell death in leukemiaH G Otten, W G J van Ginkel, A Hagenbeek, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Pharmacy World & Science : PWS|November 24, 1995
Prospects of immunotherapy for rheumatoid arthritisB A t Hart, H G Otten
Frontiers in Immunology|September 8, 2022
Editorial: A hill of needs: Non-HLA antibodies and transplantationH G Otten, Mélanie Dieudé, Michelle J Hickey
Scandinavian Journal of Rheumatology. Supplement|January 1, 1995
Rheumatoid factor production in the jointF C Breedveld, H G Otten, M R Daha
Immunology Today|June 1, 1996
Primary T-cell responses induced by B7-transfected keratinocytesH G Otten, C Ververs, G C de Gast
Leukemia & Lymphoma|June 28, 2001
Prevention of acute graft-versus-host-disease by selective depletion of T cells reactive with minor histocompatibility antigens on epithelial cellsH G Otten, A M Van Dyk, L F Verdonck
Transplant Immunology|September 8, 2014
Humoral immunity and complement effector mechanisms after lung transplantationK Budding, E A van de Graaf, H G Otten
British Journal of Rheumatology|July 1, 1993
The relation between class-specific serum rheumatoid factors and age in the general populationD van Schaardenburg, A M Lagaay, H G Otten, et al.
Scandinavian Journal of Immunology|July 1, 1992
Reactivity and self-association in vivo of a human monoclonal IgG rheumatoid factorH G Otten, M R Daha, H H De Rooy, et al.
Clinical and Experimental Rheumatology|November 1, 1995
Clinical application of the polymerase chain reaction in the detection of HLA-B27 allelesH G Otten, M van Soest, J W Bijlsma, et al.
Leukemia|June 25, 2004
Prevalence and clinical significance of resistance to perforin- and FAS-mediated cell death in leukemiaH G Otten, W G J van Ginkel, A Hagenbeek, et al.
Pageof 6